Stem definition | Drug id | CAS RN |
---|---|---|
antihistaminics | 977 | 90729-43-4 |
Dose | Unit | Route |
---|---|---|
10 | mg | O |
Property | Value | Reference |
---|---|---|
BDDCS (Biopharmaceutical Drug Disposition Classification System) | 2 | Benet LZ, Broccatelli F, Oprea TI |
EoM (Fraction excreted unchanged in urine) | 2 % | Benet LZ, Broccatelli F, Oprea TI |
MRTD (Maximum Recommended Therapeutic Daily Dose) | 0.61 µM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
Date | Agency | Company | Orphan |
---|---|---|---|
Jan. 1, 1990 | YEAR INTRODUCED |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Urticaria | 108.19 | 22.09 | 78 | 3073 | 135807 | 53210108 |
Allergy test positive | 75.61 | 22.09 | 14 | 3137 | 381 | 53345534 |
Gallbladder polyp | 66.24 | 22.09 | 14 | 3137 | 759 | 53345156 |
Angioedema | 52.40 | 22.09 | 32 | 3119 | 42044 | 53303871 |
Drug reaction with eosinophilia and systemic symptoms | 43.55 | 22.09 | 26 | 3125 | 32774 | 53313141 |
Mixed liver injury | 27.87 | 22.09 | 10 | 3141 | 3923 | 53341992 |
Mechanical urticaria | 27.42 | 22.09 | 6 | 3145 | 383 | 53345532 |
Sprue-like enteropathy | 26.00 | 22.09 | 6 | 3145 | 487 | 53345428 |
Oesophagitis | 25.84 | 22.09 | 14 | 3137 | 14663 | 53331252 |
Pyrexia | 24.35 | 22.09 | 65 | 3086 | 403128 | 52942787 |
Rhinorrhoea | 23.88 | 22.09 | 22 | 3129 | 53556 | 53292359 |
Aspartate aminotransferase increased | 23.77 | 22.09 | 27 | 3124 | 84002 | 53261913 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Dental caries | 79.28 | 25.71 | 23 | 1897 | 4621 | 32506985 |
Vitamin D deficiency | 57.12 | 25.71 | 19 | 1901 | 5975 | 32505631 |
Diabetes mellitus inadequate control | 54.82 | 25.71 | 23 | 1897 | 13745 | 32497861 |
Blood pressure fluctuation | 49.44 | 25.71 | 24 | 1896 | 20111 | 32491495 |
Hepatitis | 42.91 | 25.71 | 23 | 1897 | 23670 | 32487936 |
Musculoskeletal stiffness | 34.53 | 25.71 | 24 | 1896 | 39240 | 32472366 |
Eczema | 34.20 | 25.71 | 17 | 1903 | 14963 | 32496643 |
Colitis | 32.81 | 25.71 | 22 | 1898 | 33929 | 32477677 |
Hypocoagulable state | 31.28 | 25.71 | 8 | 1912 | 1000 | 32510606 |
Gastrointestinal disorder | 29.78 | 25.71 | 20 | 1900 | 30911 | 32480695 |
Haematochezia | 27.71 | 25.71 | 21 | 1899 | 39187 | 32472419 |
Rheumatoid arthritis | 27.45 | 25.71 | 22 | 1898 | 44522 | 32467084 |
Source | Code | Description |
---|---|---|
ATC | R06AX22 | RESPIRATORY SYSTEM ANTIHISTAMINES FOR SYSTEMIC USE ANTIHISTAMINES FOR SYSTEMIC USE Other antihistamines for systemic use |
MeSH PA | D018494 | Histamine Agents |
MeSH PA | D006633 | Histamine Antagonists |
MeSH PA | D006634 | Histamine H1 Antagonists |
MeSH PA | D018377 | Neurotransmitter Agents |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Allergic rhinitis | indication | 61582004 | |
Chronic idiopathic urticaria | indication | 302162004 |
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 8.87 | Basic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Histamine H1 receptor | GPCR | ANTAGONIST | Ki | 8 | WOMBAT-PK | SCIENTIFIC LITERATURE | |||
D(2) dopamine receptor | GPCR | IC50 | 7.21 | CHEMBL | |||||
Alpha-2A adrenergic receptor | GPCR | Ki | 6.51 | DRUG MATRIX | |||||
Potassium voltage-gated channel subfamily H member 2 | Ion channel | IC50 | 6.55 | WOMBAT-PK | |||||
Multidrug resistance protein 1 | Transporter | IC50 | 5.82 | CHEMBL | |||||
Sodium-dependent serotonin transporter | Transporter | Ki | 6.19 | DRUG MATRIX | |||||
Sodium-dependent noradrenaline transporter | Transporter | Ki | 6.34 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 1A | GPCR | IC50 | 7.33 | CHEMBL | |||||
5-hydroxytryptamine receptor 2A | GPCR | Ki | 7.59 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 2B | GPCR | Ki | 6.70 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 2C | GPCR | Ki | 6.91 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 6 | GPCR | Ki | 5.99 | DRUG MATRIX | |||||
Alpha-2B adrenergic receptor | GPCR | Ki | 6.47 | DRUG MATRIX | |||||
D(3) dopamine receptor | GPCR | Ki | 7.38 | DRUG MATRIX | |||||
Histamine H2 receptor | GPCR | Ki | 5.54 | DRUG MATRIX | |||||
Muscarinic acetylcholine receptor M1 | GPCR | IC50 | 5.96 | CHEMBL | |||||
Muscarinic acetylcholine receptor M2 | GPCR | Ki | 6.55 | DRUG MATRIX | |||||
Muscarinic acetylcholine receptor M3 | GPCR | Ki | 6.86 | DRUG MATRIX | |||||
D(1A) dopamine receptor | GPCR | Ki | 6.22 | DRUG MATRIX | |||||
Muscarinic acetylcholine receptor M5 | GPCR | Ki | 6.62 | DRUG MATRIX | |||||
Beta-3 adrenergic receptor | GPCR | Ki | 5.72 | DRUG MATRIX | |||||
Alpha-2C adrenergic receptor | GPCR | Ki | 7.40 | DRUG MATRIX | |||||
Sodium-dependent dopamine transporter | Transporter | Ki | 7.11 | DRUG MATRIX | |||||
Adenosine receptor A3 | GPCR | Ki | 5.74 | DRUG MATRIX | |||||
D(4) dopamine receptor | GPCR | Ki | 6.34 | DRUG MATRIX | |||||
Alpha-1D adrenergic receptor | GPCR | Ki | 6.06 | DRUG MATRIX | |||||
Acetylcholinesterase | Enzyme | IC50 | 5.13 | DRUG MATRIX | |||||
Epidermal growth factor receptor | Kinase | IC50 | 6.25 | DRUG MATRIX | |||||
Tyrosine-protein kinase Fyn | Kinase | IC50 | 6.09 | DRUG MATRIX | |||||
Receptor tyrosine-protein kinase erbB-2 | Kinase | IC50 | 5.98 | DRUG MATRIX | |||||
Substance-K receptor | GPCR | Ki | 6.19 | DRUG MATRIX | |||||
Muscarinic acetylcholine receptor M4 | GPCR | Ki | 6.94 | DRUG MATRIX | |||||
Alpha-1B adrenergic receptor | GPCR | Ki | 6.63 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 1B | GPCR | Ki | 5.85 | DRUG MATRIX | |||||
Membrane-associated progesterone receptor component 1 | Membrane receptor | Ki | 5.87 | DRUG MATRIX | |||||
Alpha-1A adrenergic receptor | GPCR | IC50 | 5.58 | CHEMBL | |||||
Histamine H1 receptor | GPCR | IC50 | 7.35 | CHEMBL |
ID | Source |
---|---|
D01478 | KEGG_DRUG |
C0058895 | UMLSCUI |
CHEBI:31528 | CHEBI |
CHEMBL305660 | ChEMBL_ID |
DB11742 | DRUGBANK_ID |
C058249 | MESH_SUPPLEMENTAL_RECORD_UI |
5633 | INN_ID |
TQD7Q784P1 | UNII |
3191 | PUBCHEM_CID |
23796 | RXNORM |
007136 | NDDF |
None